These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19513947)

  • 21. Newer monoclonal antibodies for hematological malignancies.
    Castillo J; Winer E; Quesenberry P
    Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.
    Doronina SO; Mendelsohn BA; Bovee TD; Cerveny CG; Alley SC; Meyer DL; Oflazoglu E; Toki BE; Sanderson RJ; Zabinski RF; Wahl AF; Senter PD
    Bioconjug Chem; 2006; 17(1):114-24. PubMed ID: 16417259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro.
    Bieber MM; Twist CJ; Bhat NM; Teng NN
    Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies.
    Blanc V; Bousseau A; Caron A; Carrez C; Lutz RJ; Lambert JM
    Clin Cancer Res; 2011 Oct; 17(20):6448-58. PubMed ID: 22003072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells.
    Hayden-Ledbetter MS; Cerveny CG; Espling E; Brady WA; Grosmaire LS; Tan P; Bader R; Slater S; Nilsson CA; Barone DS; Simon A; Bradley C; Thompson PA; Wahl AF; Ledbetter JA
    Clin Cancer Res; 2009 Apr; 15(8):2739-46. PubMed ID: 19351771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells.
    Wulf GG; Boehnke A; Chapuy B; Glass B; Hemmerlein B; Schroers R; Brenner MK; Truemper L
    Haematologica; 2006 Jul; 91(7):886-94. PubMed ID: 16818275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft models.
    Kawai S; Yoshimura Y; Iida S; Kinoshita Y; Koishihara Y; Ozaki S; Matsumoto T; Kosaka M; Yamada-Okabe H
    Oncol Rep; 2006 Feb; 15(2):361-7. PubMed ID: 16391855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.
    Funakoshi S; Longo DL; Murphy WJ
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):93-101. PubMed ID: 8732692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
    Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
    Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.
    't Hart BA; Hintzen RQ; Laman JD
    Neurodegener Dis; 2008; 5(1):38-52. PubMed ID: 18075274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.
    Kuhne MR; Mulvey T; Belanger B; Chen S; Pan C; Chong C; Cao F; Niekro W; Kempe T; Henning KA; Cohen LJ; Korman AJ; Cardarelli PM
    Clin Cancer Res; 2013 Jan; 19(2):357-66. PubMed ID: 23213054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
    Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
    Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating temsirolimus activity in multiple tumors: a review of clinical trials.
    Dancey JE; Curiel R; Purvis J
    Semin Oncol; 2009 Dec; 36 Suppl 3():S46-58. PubMed ID: 19963100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology and clinical applications of CD40 in cancer treatment.
    Fonsatti E; Maio M; Altomonte M; Hersey P
    Semin Oncol; 2010 Oct; 37(5):517-23. PubMed ID: 21074067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of galiximab in non-Hodgkin lymphoma.
    Vinjamaram S; Czuczman MS; Hernandez-Ilizaliturri FJ
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):277-82. PubMed ID: 18854281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer.
    Rosevear HM; Lightfoot AJ; Griffith TS
    Curr Opin Investig Drugs; 2010 Jun; 11(6):688-98. PubMed ID: 20496264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12).
    Laman JD; 't Hart BA; Brok H; Meurs Mv; Schellekens MM; Kasran A; Boon L; Bauer J; Boer Md; Ceuppens J
    Eur J Immunol; 2002 Aug; 32(8):2218-28. PubMed ID: 12209634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies.
    Hutas G
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1206-15. PubMed ID: 18951300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CD40 in Waldenström's macroglobulinemia.
    Lee M; Advani R
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):87-9. PubMed ID: 19362983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.